Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages

AIDS Research and Human Retroviruses

Volumn 12, Issue 3, 1996, Pages 195-198

  Wen Zhe, Ho ^a   Cnaan, Avital ^a   Li, Yu Hua ^a   Zhao, Huaqing ^a   Lee, Hae Ran ^a   Song, Li ^a   Douglas, Steven D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; IMMUNOMODULATING AGENT; RNA DIRECTED DNA POLYMERASE; SUBSTANCE P;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INOCULATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0030040791     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.195     Document Type: Article

References (31)

1. Felton DL, Cohen N, Ader R, Felton ST, Carlson SL, and Rossman TL: Central neural circuits involved in neural-immune interactions. In: Psychoneuroimmunology (Ader R, Felton DL, and Cohen N, eds.) 2nd Ed. Academic Press, San Diego, California, 1991, pp. 3-18.
2. Morley JE, Kay NE, Solomon GF, and Plotnikoff NP: Neuropeptides: Conductors of the immune orchestra. Life Sci 1987;41:527-544.
3. Dunn AJ: Nervous system-immune system interactions: An overview. J Receptor Res 1988;8:589-607.
4. Payan DG: Neuropeptides and inflammation: The role of substance P. Annu Rev Med 1989;40:341-352.
5. McGillis JP, Mitsubashi M, and Payan DG: Immunomodulation by tachykinin neuropeptides. Ann NY Acad Sci 1990;594:85-94.
6. Jonakait GM, Schotland S, and Hart RP: Effects of lymphokines on substance P in injured ganglia of the peripheral nervous system. Ann NY Acad Sci 1991;632:19-30.
7. Lotz M, Vaughan JH, and Carson DA: Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1211-1221.
8. Laurenzi MA, Persson MA, Dalsgaard C-J, and Haegerstrand A: The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: Activated cells are preferentially influenced by the neuropeptide. Scand J Immunol 1990;31:529-533.
9. Lee H-R, Ho W-H, and Douglas SD: Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. Clin Diagn Lab Immunol 1994;1:419-123.
10. Lucey DR, Novak JM, Polonis VR, Liu Y, and Gartner S: Characterization of substance P binding to human monocytes/macrophages. Clin Diagn Lab Immunol 1995;1:330-335.
11. Jeurissen F, Kavelaars A, Korstjens M, Broeke D, Franklin RA, Gelfand EW, and Heijnen CJ: Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. J Immunol 1994;152:2987-2992.
12. i protein, calcium, phospholipase D, MAP kinase, and IL-6 production. J Immunol 1994;153:3691-3699.
13. Harrowe G, Mitsuhashi M, and Payan DG: Measles virus-substance P receptor interaction: Possible novel mechanism of viral fusion. J Clin Invest 1990;85:1324-1327.
14. Gallaher WR: Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 1987;50:327-328.
15. Hassan NF and Douglas SD: Stress-related neuroimmunomodulation of monocyte-macrophage functions in HIV-1 infection. Clin Immunol Immunopathol 1990;54:220-227.
16. Hartung HP: Activation of macrophages by neuropeptides. Brain Behav Immunol 1988;2:275-281.
17. Azzari C, Rossi ME, Resti M, Caldini AL, Galli L, Fico E, and Vierucci A: Imbalance in the levels of substance P and somatostatin in HIV-positive children. Ped Med Chir [Med Surg Ped] 1992;14:577-581.
18. Sharkey KA, Sutherland LR, Davison JS, Zwier H, Gill MJ, Church DL, and the GI/HIV Study Group of the University of Calvary: Peptides in the gastrointestinal tract in human immunodeficiency virus infection. Gastroenterology 1992;103:18-28.
19. Covas MJ, Pinto LA, and Victorino RMM: Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV-1 infection. Clin Exp Immunol 1994;96:384.
20. Hassan NF, Campbell DE, and Douglas SD: Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods 1986;95:273-276.
21. Hassan NF, Cutilli JR, and Douglas SD: Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocytes/macrophages. J Immunol Methods 1990; 130:283-285.
22. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, and Martin MA: In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988;62:139-147.
23. Hogan MM and Vogel SN: Measurement of tumor necrosis factor a and b. In: Current Protocols in Immunology. Greene Publishing Associates and Wiley-Interscience, New York, 1991, pp. 6.10.1-6.10.5.
24. Flick DA and Gifford GE: Comparison of in vitro cytotoxic assay for tumor necrosis factor. J Immunol Methods 1984;68:167-175.
25. Ho W-Z, Cherukuri R, and Douglas SD: Macrophage and human immunodeficiency virus type 1. In: Macrophage-Pathogen Interactions (Zwilling BS and Einstein TK, eds.). Marcel Dekker, Inc., New York, 1993, pp. 569-587.
26. Collman R, Hassan NF, Walker R, Godfrey B, Cutilli JR, Hastings J, Friedman H, Douglas SD, and Nathanson N: Infection of monocyte-derived macrophages with HIV-1. J Exp Med 1989; 170:1149-1163.
27. Chang J, Li-S, Naif H, and Cunningham AL: The magnitude of HIV replication in monocytes and macrophages is influenced by environmental conditions, viral strain, and host cells. J Leukocyte Biol 1994;56:230-235.
28. Olafsson K, Smith MS, Marshburn P, Carter SG, and Haskill S: Variation of HIV infectivity of macrophages as a function of donor, stage of differentiation, and site of origin. J AIDS 1991;4:154-164.
29. Co MS, Gaulton GN, Tominaga A, Homcy CJ, Field BN, and Greene MI: Structural similarities between the mammalian β-adrenergic and retrovirus type 3 receptors. Proc Natl Acad Sci USA 1985;82:5315-5319.
30. Epstein DA, Marsh YV, Shreiber AB, Newman SR, Todaro GJ, and Nestor JJ: Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature (London) 1985;318:663-665.
31. Harrowe G, Sudduth-Klinger J, and Payan DG: Measles virus-substance P receptor interactions: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication. Cell Mol Neurobiol 1992;12:397-409.